New study continues to refine most effective methods to predict Alzheimer's disease

Jul 14, 2009

A new Mayo Clinic study found that the clinical criteria for mild cognitive impairment is better at predicting who will develop Alzheimer's disease than a single memory test. This is one more piece of information to aid in the identification and early treatment of individuals most likely to develop Alzheimer's disease. This study will be presented at the Alzheimer's Association International Conference on Alzheimer's Disease on July 14 in Vienna.

Alzheimer's disease is a degenerative disorder of the brain in which nerve cells die over time, resulting in a steady loss of memory and other thinking abilities. An estimated 5.3 million Americans are living with Alzheimer's disease, and it is the sixth-leading cause of death in the U.S. Mild is a transitional state between normal aging and the earliest features of Alzheimer's disease.

"The goal of this research is to try to predict who is going to develop Alzheimer's disease in the future," says Ronald Petersen, M.D., Ph.D., a neurologist at Mayo Clinic and the lead author of this study. "Ideally, we'd like to identify individuals before any damage is done in the brain. The sooner we intervene on this process with medications or other therapies, the greater impact we can have on lessening the number of people who will ultimately develop Alzheimer's disease."

Dr. Petersen and his team studied 1,261 individuals aged 70 years who were cognitively normal or had only slight memory impairment at the onset of the study. The individuals were followed for up to 10 years. Scores on a memory test and the clinical criteria for (including a as well as other assessments of cognitive function) were studied as possible predictors for eventual development of Alzheimer's disease. The team found that the clinical criteria for mild cognitive impairment was better able to predict who was going to develop Alzheimer's disease in the future.

"As the baby boomers age into the period of risk for , we're talking about a significant number of individuals who may become cognitively impaired in the very near future," says Dr. Petersen. "Consequently, we need information like this about the best methods of early prediction so that we can develop therapies to prevent or treat the condition and avoid being overwhelmed by the burden of these individuals on the health care system."

Source: Mayo Clinic (news : web)

Explore further: EU ready for Ebola threat: sources

add to favorites email to friend print save as pdf

Related Stories

Education protects against pre-Alzheimer's memory loss

Oct 20, 2008

ST. PAUL, Minn. – People with more education and more mentally demanding occupations may have protection against the memory loss that precedes Alzheimer's disease, according to a study published in the October 21, 2008, ...

Loss of scent sense linked to Alzheimer's

Jul 04, 2007

A new study shows seniors who have trouble identifying scents are more likely to develop Alzheimer's disease than people who knew soap smell from cinnamon.

MRI shows brain atrophy pattern that predicts Alzheimer's

Feb 10, 2009

Using special MRI methods, researchers have identified a pattern of regional brain atrophy in patients with mild cognitive impairment (MCI) that indicates a greater likelihood of progression to Alzheimer's disease. The findings ...

Recommended for you

EU ready for Ebola threat: sources

1 hour ago

The European Union is equipped and ready to treat victims should the deadly Ebola virus, which has killed hundreds in West Africa, be found in member states, EU sources said Wednesday.

Reducing kidney injury using a quality improvement method

5 hours ago

Using quality improvement measures in eight of the 10 hospitals in the Northern New England Cardiovascular Disease Study Group, researchers have found a way to reduce kidney injury in patients undergoing a procedure with ...

App for headache sufferers shows success

18 hours ago

A unique app that helps headache sufferers to record the severity and regularity of their pain is being used as part of a Griffith research study.

User comments : 1

Adjust slider to filter visible comments by rank

Display comments: newest first

googleplex
not rated yet Jul 14, 2009
Ideally, we'd like to identify individuals before any damage is done in the brain.


The best test is to identify individuals with APOE-4 genotypes and then screen for Herpes Simplex A. These are the highest correlated factors discovered that I have heard of.

I agree that trying to detect the disease after the fact by using congnitive testing is too late.

In any case what is the advantage of early detection? As there is currently no cure and only questionable treatments that enrich big pharma.

So we are left with the usual factors e.g. keeping physically and mentally fit and active.